nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolterodine—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.15	0.222	CbGbCtD
Tolterodine—CYP2C19—Progesterone—uterine cancer	0.119	0.177	CbGbCtD
Tolterodine—CYP2C9—Progesterone—uterine cancer	0.0992	0.147	CbGbCtD
Tolterodine—CYP2D6—Progesterone—uterine cancer	0.0907	0.134	CbGbCtD
Tolterodine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0871	0.129	CbGbCtD
Tolterodine—CYP3A4—Progesterone—uterine cancer	0.0577	0.0855	CbGbCtD
Tolterodine—CYP2D6—Doxorubicin—uterine cancer	0.0277	0.041	CbGbCtD
Tolterodine—CYP3A4—Etoposide—uterine cancer	0.0258	0.0382	CbGbCtD
Tolterodine—CHRM3—ureter—uterine cancer	0.0255	0.305	CbGeAlD
Tolterodine—CHRM3—muscle of abdomen—uterine cancer	0.0183	0.22	CbGeAlD
Tolterodine—CYP3A4—Doxorubicin—uterine cancer	0.0176	0.0261	CbGbCtD
Tolterodine—Xerophthalmia—Progesterone—uterine cancer	0.0167	0.0692	CcSEcCtD
Tolterodine—Influenza-like symptoms—Progesterone—uterine cancer	0.00631	0.0261	CcSEcCtD
Tolterodine—Memory impairment—Progesterone—uterine cancer	0.00575	0.0238	CcSEcCtD
Tolterodine—CHRM3—exocrine gland—uterine cancer	0.00502	0.0601	CbGeAlD
Tolterodine—Influenza like illness—Progesterone—uterine cancer	0.00438	0.0181	CcSEcCtD
Tolterodine—Abnormal vision—Progesterone—uterine cancer	0.00393	0.0163	CcSEcCtD
Tolterodine—CHRM5—epithelium—uterine cancer	0.0039	0.0468	CbGeAlD
Tolterodine—Disorientation—Progesterone—uterine cancer	0.00366	0.0151	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Progesterone—uterine cancer	0.00338	0.014	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Medroxyprogesterone Acetate—uterine cancer	0.00306	0.0127	CcSEcCtD
Tolterodine—Infection—Carboplatin—uterine cancer	0.00304	0.0126	CcSEcCtD
Tolterodine—Urinary retention—Medroxyprogesterone Acetate—uterine cancer	0.00282	0.0117	CcSEcCtD
Tolterodine—Bronchitis—Progesterone—uterine cancer	0.00272	0.0113	CcSEcCtD
Tolterodine—Dry skin—Medroxyprogesterone Acetate—uterine cancer	0.00272	0.0112	CcSEcCtD
Tolterodine—Dysuria—Progesterone—uterine cancer	0.00265	0.0109	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Progesterone—uterine cancer	0.00263	0.0109	CcSEcCtD
Tolterodine—Pain—Carboplatin—uterine cancer	0.00262	0.0108	CcSEcCtD
Tolterodine—Weight increased—Progesterone—uterine cancer	0.00257	0.0106	CcSEcCtD
Tolterodine—KCNH2—myometrium—uterine cancer	0.00247	0.0295	CbGeAlD
Tolterodine—Bronchitis—Medroxyprogesterone Acetate—uterine cancer	0.00247	0.0102	CcSEcCtD
Tolterodine—Urinary tract infection—Progesterone—uterine cancer	0.00245	0.0101	CcSEcCtD
Tolterodine—Dysuria—Medroxyprogesterone Acetate—uterine cancer	0.0024	0.00991	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Medroxyprogesterone Acetate—uterine cancer	0.00238	0.00985	CcSEcCtD
Tolterodine—Sinusitis—Progesterone—uterine cancer	0.00237	0.00979	CcSEcCtD
Tolterodine—Weight increased—Medroxyprogesterone Acetate—uterine cancer	0.00233	0.00965	CcSEcCtD
Tolterodine—Oedema peripheral—Progesterone—uterine cancer	0.00223	0.00922	CcSEcCtD
Tolterodine—Urinary tract infection—Medroxyprogesterone Acetate—uterine cancer	0.00222	0.00919	CcSEcCtD
Tolterodine—Visual impairment—Progesterone—uterine cancer	0.00218	0.00902	CcSEcCtD
Tolterodine—Sinusitis—Medroxyprogesterone Acetate—uterine cancer	0.00214	0.00887	CcSEcCtD
Tolterodine—CHRM3—smooth muscle tissue—uterine cancer	0.0021	0.0252	CbGeAlD
Tolterodine—CHRM3—renal system—uterine cancer	0.00202	0.0243	CbGeAlD
Tolterodine—Oedema peripheral—Medroxyprogesterone Acetate—uterine cancer	0.00202	0.00836	CcSEcCtD
Tolterodine—Visual impairment—Medroxyprogesterone Acetate—uterine cancer	0.00198	0.00818	CcSEcCtD
Tolterodine—Flatulence—Progesterone—uterine cancer	0.00194	0.00803	CcSEcCtD
Tolterodine—KCNH2—uterine cervix—uterine cancer	0.00192	0.023	CbGeAlD
Tolterodine—CHRM1—female reproductive system—uterine cancer	0.00181	0.0217	CbGeAlD
Tolterodine—Angioedema—Progesterone—uterine cancer	0.0018	0.00745	CcSEcCtD
Tolterodine—KCNH2—renal system—uterine cancer	0.0018	0.0215	CbGeAlD
Tolterodine—Vertigo—Progesterone—uterine cancer	0.00177	0.00732	CcSEcCtD
Tolterodine—Flatulence—Medroxyprogesterone Acetate—uterine cancer	0.00176	0.00728	CcSEcCtD
Tolterodine—Palpitations—Progesterone—uterine cancer	0.00174	0.0072	CcSEcCtD
Tolterodine—KCNH2—endometrium—uterine cancer	0.00174	0.0208	CbGeAlD
Tolterodine—Anaphylactoid reaction—Etoposide—uterine cancer	0.00173	0.00715	CcSEcCtD
Tolterodine—Arthralgia—Progesterone—uterine cancer	0.00168	0.00694	CcSEcCtD
Tolterodine—Chest pain—Progesterone—uterine cancer	0.00168	0.00694	CcSEcCtD
Tolterodine—Anxiety—Progesterone—uterine cancer	0.00167	0.00692	CcSEcCtD
Tolterodine—Dry mouth—Progesterone—uterine cancer	0.00164	0.00679	CcSEcCtD
Tolterodine—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.00163	0.00675	CcSEcCtD
Tolterodine—Confusional state—Progesterone—uterine cancer	0.00162	0.00671	CcSEcCtD
Tolterodine—CHRM3—female reproductive system—uterine cancer	0.00162	0.0194	CbGeAlD
Tolterodine—Oedema—Progesterone—uterine cancer	0.00161	0.00665	CcSEcCtD
Tolterodine—Anaphylactic shock—Progesterone—uterine cancer	0.00161	0.00665	CcSEcCtD
Tolterodine—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.0016	0.00664	CcSEcCtD
Tolterodine—KCNH2—uterus—uterine cancer	0.0016	0.0192	CbGeAlD
Tolterodine—Infection—Progesterone—uterine cancer	0.0016	0.00661	CcSEcCtD
Tolterodine—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00158	0.00653	CcSEcCtD
Tolterodine—Tachycardia—Progesterone—uterine cancer	0.00157	0.00649	CcSEcCtD
Tolterodine—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.00152	0.00629	CcSEcCtD
Tolterodine—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.00152	0.00629	CcSEcCtD
Tolterodine—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.00152	0.00627	CcSEcCtD
Tolterodine—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00149	0.00615	CcSEcCtD
Tolterodine—Flushing—Dactinomycin—uterine cancer	0.00149	0.00614	CcSEcCtD
Tolterodine—CHRM3—female gonad—uterine cancer	0.00148	0.0177	CbGeAlD
Tolterodine—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00147	0.00608	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00147	0.00606	CcSEcCtD
Tolterodine—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00146	0.00603	CcSEcCtD
Tolterodine—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00146	0.00603	CcSEcCtD
Tolterodine—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00145	0.00599	CcSEcCtD
Tolterodine—KCNH2—female reproductive system—uterine cancer	0.00144	0.0172	CbGeAlD
Tolterodine—Somnolence—Progesterone—uterine cancer	0.00143	0.00591	CcSEcCtD
Tolterodine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00142	0.00588	CcSEcCtD
Tolterodine—Dyspepsia—Progesterone—uterine cancer	0.00142	0.00586	CcSEcCtD
Tolterodine—Fatigue—Progesterone—uterine cancer	0.00139	0.00574	CcSEcCtD
Tolterodine—Constipation—Progesterone—uterine cancer	0.00138	0.00569	CcSEcCtD
Tolterodine—Pain—Progesterone—uterine cancer	0.00138	0.00569	CcSEcCtD
Tolterodine—CYP2C19—vagina—uterine cancer	0.00136	0.0163	CbGeAlD
Tolterodine—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00133	0.00549	CcSEcCtD
Tolterodine—Feeling abnormal—Progesterone—uterine cancer	0.00133	0.00548	CcSEcCtD
Tolterodine—Gastrointestinal pain—Progesterone—uterine cancer	0.00132	0.00544	CcSEcCtD
Tolterodine—KCNH2—female gonad—uterine cancer	0.00131	0.0157	CbGeAlD
Tolterodine—KCNH2—vagina—uterine cancer	0.0013	0.0156	CbGeAlD
Tolterodine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.0013	0.00536	CcSEcCtD
Tolterodine—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00128	0.00531	CcSEcCtD
Tolterodine—Abdominal pain—Progesterone—uterine cancer	0.00127	0.00526	CcSEcCtD
Tolterodine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00126	0.0052	CcSEcCtD
Tolterodine—Influenza like illness—Epirubicin—uterine cancer	0.00126	0.00519	CcSEcCtD
Tolterodine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00125	0.00515	CcSEcCtD
Tolterodine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.0012	0.00497	CcSEcCtD
Tolterodine—Dry eye—Epirubicin—uterine cancer	0.00119	0.00494	CcSEcCtD
Tolterodine—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00119	0.00493	CcSEcCtD
Tolterodine—Hypersensitivity—Progesterone—uterine cancer	0.00119	0.0049	CcSEcCtD
Tolterodine—CYP2C9—female reproductive system—uterine cancer	0.00117	0.014	CbGeAlD
Tolterodine—Influenza like illness—Doxorubicin—uterine cancer	0.00116	0.0048	CcSEcCtD
Tolterodine—Asthenia—Progesterone—uterine cancer	0.00115	0.00477	CcSEcCtD
Tolterodine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00115	0.00477	CcSEcCtD
Tolterodine—Oedema—Dactinomycin—uterine cancer	0.00114	0.0047	CcSEcCtD
Tolterodine—Infection—Dactinomycin—uterine cancer	0.00113	0.00467	CcSEcCtD
Tolterodine—Abnormal vision—Epirubicin—uterine cancer	0.00113	0.00466	CcSEcCtD
Tolterodine—CYP3A4—renal system—uterine cancer	0.00111	0.0133	CbGeAlD
Tolterodine—Dry eye—Doxorubicin—uterine cancer	0.00111	0.00457	CcSEcCtD
Tolterodine—Diarrhoea—Progesterone—uterine cancer	0.0011	0.00455	CcSEcCtD
Tolterodine—CYP2D6—renal system—uterine cancer	0.00109	0.0131	CbGeAlD
Tolterodine—Flushing—Etoposide—uterine cancer	0.00108	0.00445	CcSEcCtD
Tolterodine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00107	0.00444	CcSEcCtD
Tolterodine—Dizziness—Progesterone—uterine cancer	0.00106	0.0044	CcSEcCtD
Tolterodine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00105	0.00433	CcSEcCtD
Tolterodine—Abnormal vision—Doxorubicin—uterine cancer	0.00104	0.00431	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00104	0.00428	CcSEcCtD
Tolterodine—Headache—Progesterone—uterine cancer	0.00101	0.00417	CcSEcCtD
Tolterodine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000997	0.00412	CcSEcCtD
Tolterodine—Fatigue—Dactinomycin—uterine cancer	0.00098	0.00405	CcSEcCtD
Tolterodine—Pain—Dactinomycin—uterine cancer	0.000972	0.00402	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Epirubicin—uterine cancer	0.00097	0.00401	CcSEcCtD
Tolterodine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000964	0.00399	CcSEcCtD
Tolterodine—Feeling abnormal—Dactinomycin—uterine cancer	0.000937	0.00387	CcSEcCtD
Tolterodine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00093	0.00384	CcSEcCtD
Tolterodine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000913	0.00378	CcSEcCtD
Tolterodine—Vertigo—Etoposide—uterine cancer	0.000906	0.00375	CcSEcCtD
Tolterodine—Abdominal pain—Dactinomycin—uterine cancer	0.000899	0.00372	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.000897	0.00371	CcSEcCtD
Tolterodine—CYP3A4—female reproductive system—uterine cancer	0.000891	0.0107	CbGeAlD
Tolterodine—CYP2D6—female reproductive system—uterine cancer	0.000877	0.0105	CbGeAlD
Tolterodine—Dry skin—Epirubicin—uterine cancer	0.00086	0.00356	CcSEcCtD
Tolterodine—Chest pain—Etoposide—uterine cancer	0.000859	0.00355	CcSEcCtD
Tolterodine—KCNH2—lymph node—uterine cancer	0.000841	0.0101	CbGeAlD
Tolterodine—Hypersensitivity—Dactinomycin—uterine cancer	0.000838	0.00346	CcSEcCtD
Tolterodine—Confusional state—Etoposide—uterine cancer	0.00083	0.00343	CcSEcCtD
Tolterodine—Anaphylactic shock—Etoposide—uterine cancer	0.000823	0.0034	CcSEcCtD
Tolterodine—Infection—Etoposide—uterine cancer	0.000818	0.00338	CcSEcCtD
Tolterodine—Asthenia—Dactinomycin—uterine cancer	0.000816	0.00337	CcSEcCtD
Tolterodine—Tachycardia—Etoposide—uterine cancer	0.000803	0.00332	CcSEcCtD
Tolterodine—CYP2D6—female gonad—uterine cancer	0.000798	0.00956	CbGeAlD
Tolterodine—Dry skin—Doxorubicin—uterine cancer	0.000796	0.00329	CcSEcCtD
Tolterodine—Bronchitis—Epirubicin—uterine cancer	0.00078	0.00323	CcSEcCtD
Tolterodine—Diarrhoea—Dactinomycin—uterine cancer	0.000778	0.00322	CcSEcCtD
Tolterodine—Dysuria—Epirubicin—uterine cancer	0.000759	0.00314	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000754	0.00312	CcSEcCtD
Tolterodine—Weight increased—Epirubicin—uterine cancer	0.000738	0.00305	CcSEcCtD
Tolterodine—Somnolence—Etoposide—uterine cancer	0.000732	0.00303	CcSEcCtD
Tolterodine—Bronchitis—Doxorubicin—uterine cancer	0.000722	0.00298	CcSEcCtD
Tolterodine—Fatigue—Etoposide—uterine cancer	0.00071	0.00293	CcSEcCtD
Tolterodine—Constipation—Etoposide—uterine cancer	0.000704	0.00291	CcSEcCtD
Tolterodine—Pain—Etoposide—uterine cancer	0.000704	0.00291	CcSEcCtD
Tolterodine—Urinary tract infection—Epirubicin—uterine cancer	0.000703	0.00291	CcSEcCtD
Tolterodine—Dysuria—Doxorubicin—uterine cancer	0.000702	0.0029	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000698	0.00288	CcSEcCtD
Tolterodine—Weight increased—Doxorubicin—uterine cancer	0.000683	0.00282	CcSEcCtD
Tolterodine—Sinusitis—Epirubicin—uterine cancer	0.000679	0.00281	CcSEcCtD
Tolterodine—Feeling abnormal—Etoposide—uterine cancer	0.000678	0.0028	CcSEcCtD
Tolterodine—Gastrointestinal pain—Etoposide—uterine cancer	0.000673	0.00278	CcSEcCtD
Tolterodine—Abdominal pain—Etoposide—uterine cancer	0.000651	0.00269	CcSEcCtD
Tolterodine—Urinary tract infection—Doxorubicin—uterine cancer	0.000651	0.00269	CcSEcCtD
Tolterodine—Oedema peripheral—Epirubicin—uterine cancer	0.00064	0.00265	CcSEcCtD
Tolterodine—Sinusitis—Doxorubicin—uterine cancer	0.000628	0.0026	CcSEcCtD
Tolterodine—Visual impairment—Epirubicin—uterine cancer	0.000626	0.00259	CcSEcCtD
Tolterodine—Hypersensitivity—Etoposide—uterine cancer	0.000606	0.00251	CcSEcCtD
Tolterodine—Flushing—Epirubicin—uterine cancer	0.000603	0.00249	CcSEcCtD
Tolterodine—Oedema peripheral—Doxorubicin—uterine cancer	0.000592	0.00245	CcSEcCtD
Tolterodine—Asthenia—Etoposide—uterine cancer	0.00059	0.00244	CcSEcCtD
Tolterodine—Visual impairment—Doxorubicin—uterine cancer	0.000579	0.00239	CcSEcCtD
Tolterodine—Diarrhoea—Etoposide—uterine cancer	0.000563	0.00233	CcSEcCtD
Tolterodine—Flushing—Doxorubicin—uterine cancer	0.000558	0.00231	CcSEcCtD
Tolterodine—Flatulence—Epirubicin—uterine cancer	0.000557	0.0023	CcSEcCtD
Tolterodine—Dizziness—Etoposide—uterine cancer	0.000544	0.00225	CcSEcCtD
Tolterodine—Headache—Etoposide—uterine cancer	0.000516	0.00213	CcSEcCtD
Tolterodine—Flatulence—Doxorubicin—uterine cancer	0.000515	0.00213	CcSEcCtD
Tolterodine—Vertigo—Epirubicin—uterine cancer	0.000508	0.0021	CcSEcCtD
Tolterodine—Palpitations—Epirubicin—uterine cancer	0.0005	0.00207	CcSEcCtD
Tolterodine—Arthralgia—Epirubicin—uterine cancer	0.000481	0.00199	CcSEcCtD
Tolterodine—Chest pain—Epirubicin—uterine cancer	0.000481	0.00199	CcSEcCtD
Tolterodine—Anxiety—Epirubicin—uterine cancer	0.00048	0.00198	CcSEcCtD
Tolterodine—Dry mouth—Epirubicin—uterine cancer	0.000471	0.00195	CcSEcCtD
Tolterodine—Vertigo—Doxorubicin—uterine cancer	0.00047	0.00194	CcSEcCtD
Tolterodine—Confusional state—Epirubicin—uterine cancer	0.000465	0.00192	CcSEcCtD
Tolterodine—Palpitations—Doxorubicin—uterine cancer	0.000462	0.00191	CcSEcCtD
Tolterodine—Oedema—Epirubicin—uterine cancer	0.000461	0.00191	CcSEcCtD
Tolterodine—Anaphylactic shock—Epirubicin—uterine cancer	0.000461	0.00191	CcSEcCtD
Tolterodine—Infection—Epirubicin—uterine cancer	0.000458	0.0019	CcSEcCtD
Tolterodine—Tachycardia—Epirubicin—uterine cancer	0.00045	0.00186	CcSEcCtD
Tolterodine—Arthralgia—Doxorubicin—uterine cancer	0.000445	0.00184	CcSEcCtD
Tolterodine—Chest pain—Doxorubicin—uterine cancer	0.000445	0.00184	CcSEcCtD
Tolterodine—Anxiety—Doxorubicin—uterine cancer	0.000444	0.00183	CcSEcCtD
Tolterodine—Dry mouth—Doxorubicin—uterine cancer	0.000435	0.0018	CcSEcCtD
Tolterodine—Confusional state—Doxorubicin—uterine cancer	0.00043	0.00178	CcSEcCtD
Tolterodine—Anaphylactic shock—Doxorubicin—uterine cancer	0.000427	0.00177	CcSEcCtD
Tolterodine—Oedema—Doxorubicin—uterine cancer	0.000427	0.00177	CcSEcCtD
Tolterodine—Infection—Doxorubicin—uterine cancer	0.000424	0.00175	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.00042	0.00174	CcSEcCtD
Tolterodine—Tachycardia—Doxorubicin—uterine cancer	0.000417	0.00172	CcSEcCtD
Tolterodine—Somnolence—Epirubicin—uterine cancer	0.00041	0.0017	CcSEcCtD
Tolterodine—Dyspepsia—Epirubicin—uterine cancer	0.000406	0.00168	CcSEcCtD
Tolterodine—Fatigue—Epirubicin—uterine cancer	0.000398	0.00164	CcSEcCtD
Tolterodine—Pain—Epirubicin—uterine cancer	0.000395	0.00163	CcSEcCtD
Tolterodine—Constipation—Epirubicin—uterine cancer	0.000395	0.00163	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000389	0.00161	CcSEcCtD
Tolterodine—Feeling abnormal—Epirubicin—uterine cancer	0.00038	0.00157	CcSEcCtD
Tolterodine—Somnolence—Doxorubicin—uterine cancer	0.000379	0.00157	CcSEcCtD
Tolterodine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000377	0.00156	CcSEcCtD
Tolterodine—Dyspepsia—Doxorubicin—uterine cancer	0.000376	0.00155	CcSEcCtD
Tolterodine—Fatigue—Doxorubicin—uterine cancer	0.000368	0.00152	CcSEcCtD
Tolterodine—Pain—Doxorubicin—uterine cancer	0.000365	0.00151	CcSEcCtD
Tolterodine—Constipation—Doxorubicin—uterine cancer	0.000365	0.00151	CcSEcCtD
Tolterodine—Abdominal pain—Epirubicin—uterine cancer	0.000365	0.00151	CcSEcCtD
Tolterodine—Feeling abnormal—Doxorubicin—uterine cancer	0.000352	0.00145	CcSEcCtD
Tolterodine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000349	0.00144	CcSEcCtD
Tolterodine—Hypersensitivity—Epirubicin—uterine cancer	0.00034	0.00141	CcSEcCtD
Tolterodine—Abdominal pain—Doxorubicin—uterine cancer	0.000337	0.0014	CcSEcCtD
Tolterodine—Asthenia—Epirubicin—uterine cancer	0.000331	0.00137	CcSEcCtD
Tolterodine—Diarrhoea—Epirubicin—uterine cancer	0.000316	0.00131	CcSEcCtD
Tolterodine—Hypersensitivity—Doxorubicin—uterine cancer	0.000314	0.0013	CcSEcCtD
Tolterodine—Asthenia—Doxorubicin—uterine cancer	0.000306	0.00127	CcSEcCtD
Tolterodine—Dizziness—Epirubicin—uterine cancer	0.000305	0.00126	CcSEcCtD
Tolterodine—Diarrhoea—Doxorubicin—uterine cancer	0.000292	0.00121	CcSEcCtD
Tolterodine—Headache—Epirubicin—uterine cancer	0.000289	0.0012	CcSEcCtD
Tolterodine—Dizziness—Doxorubicin—uterine cancer	0.000282	0.00117	CcSEcCtD
Tolterodine—Headache—Doxorubicin—uterine cancer	0.000267	0.00111	CcSEcCtD
